Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Azitra, Inc. is a clinical-stage biopharmaceutical company developing precision dermatology therapies using engineered proteins and live biotherapeutic products derived from a proprietary microbial library of over 1,500 bacterial strains. Focusing on genetically engineered Staphylococcus epidermidis, Azitra creates topical treatments targeting rare and chronic skin diseases, leveraging AI-driven strain screening and licensed genetic engineering technologies to deliver therapeutic proteins directly into the skin for improved disease management.
This description was generated via AI from an annual report. Updated about 1 year ago.